Acute Porphyria Drugs

Monograph

D11AX18 - Diclofenac
Propably not porphyrinogenic
PNP

Rationale
Diclofenac (ATC code: D11A X18) for topical administration is safety classified as Probably not porphyrinogenic because of minimal systemic exposure and because diclofenac for systemic use (ATC code: M01A B05) is classified as Probably not porphyrinogenic (PNP). For more details of the metabolism of diclofenac please refer to the monograph of diclofenac for systemic use (ATC code: M01A B05).
Metabolism and pharmacokinetics
Absorption after topical administration is < 1-12% (SPC).
IPNet drug reports
Uneventful use reported in 4 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes D11A / D11AX or go back.
References
# Citation details PMID
*Summary of Product Characteristics
1. Norwegian medicines agency. Summary of Product Characteristics (SPC). Solaraze.

Tradenames

Diclofenaco · Solacutan · Solaraze · Soliker · Zorequin Solacutan · Solaraze Solacutan · Solaraze Solaraze Solaraze Medulan · Solacutan Diclofenac · Solaraze Solaraze Solaraze
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙